Alex Thompson's Stock Ratings

Stifel Analyst

Alex Thompson is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024

Overall Average Return

-4.04%

Smart Score

46.7%

Overall Average Return Percentile

28th

Number of Ratings

37
Buy NowGet Alert
07/22/2024MORFBuy Now
Morphic Holding
$56.470.94%$30 → $57MaintainsHoldGet Alert
06/24/2024ARGXBuy Now
argenx
$468.966.62%$485 → $500MaintainsBuyGet Alert
06/18/2024THRDBuy Now
Third Harmonic Bio
$11.8194.75% → $23Initiates → BuyGet Alert
05/31/2024ASNDBuy Now
Ascendis Pharma
$136.0047.06% → $200Initiates → BuyGet Alert
03/26/2024SYREBuy Now
Spyre Therapeutics
$29.5083.05%$36 → $54ReiteratesBuy → BuyGet Alert
02/15/2024DNTHBuy Now
Dianthus Therapeutics
$25.9269.75% → $44Initiates → BuyGet Alert
12/18/2023VTYXBuy Now
Ventyx Biosciences
$2.58-22.63%$6 → $2MaintainsHoldGet Alert
12/18/2023TVTXBuy Now
Travere Therapeutics
$9.920.81%$8 → $10MaintainsHoldGet Alert
12/18/2023SYREBuy Now
Spyre Therapeutics
$29.50-8.47%$23 → $27MaintainsBuyGet Alert
12/18/2023MLTXBuy Now
MoonLake
$44.7454.22%$66 → $69MaintainsBuyGet Alert
12/18/2023ARGXBuy Now
argenx
$468.9619.41%$557 → $560MaintainsBuyGet Alert
12/18/2023ACRSBuy Now
Aclaris Therapeutics
$1.36-26.74%$2 → $1MaintainsHoldGet Alert
11/13/2023ACRSBuy Now
Aclaris Therapeutics
$1.3646.52%$20 → $2DowngradeBuy → HoldGet Alert
11/07/2023VTYXBuy Now
Ventyx Biosciences
$2.58132.11% → $6DowngradeBuy → HoldGet Alert
11/02/2023MLTXBuy Now
MoonLake
$44.7465.4% → $74Initiates → BuyGet Alert
10/10/2023VTYXBuy Now
Ventyx Biosciences
$2.582066.34% → $56ReiteratesBuy → BuyGet Alert
09/25/2023MORFBuy Now
Morphic Holding
$56.47-41.56%$61 → $33MaintainsHoldGet Alert
09/14/2023ACRSBuy Now
Aclaris Therapeutics
$1.361365.2%$16 → $20MaintainsBuyGet Alert
09/13/2023VRDNBuy Now
Viridian Therapeutics
$14.35178.75% → $40ReiteratesBuy → BuyGet Alert
08/09/2023RAPTBuy Now
RAPT Therapeutics
$3.341097.6% → $40Initiates → BuyGet Alert
08/09/2023MORFBuy Now
Morphic Holding
$56.478.02%$69 → $61DowngradeBuy → HoldGet Alert
07/25/2023AGLEBuy Now
Aeglea BioTherapeutics
→ $22.5Initiates → BuyGet Alert
07/18/2023IMVTBuy Now
Immunovant
$27.9621.6%$28 → $34MaintainsBuyGet Alert
06/13/2023KDNYBuy Now
Chinook Therapeutics
$43 → $41DowngradeBuy → HoldGet Alert
03/30/2023IMVTBuy Now
Immunovant
$27.960.14% → $28Initiates → BuyGet Alert
03/30/2023VRDNBuy Now
Viridian Therapeutics
$14.35241.46% → $49Initiates → BuyGet Alert
12/22/2022ARGXBuy Now
argenx
$468.961.93%$471 → $478MaintainsBuyGet Alert
12/22/2022KDNYBuy Now
Chinook Therapeutics
$30 → $43MaintainsBuyGet Alert
12/14/2022ACRSBuy Now
Aclaris Therapeutics
$1.362024.54% → $29Initiates → BuyGet Alert
12/14/2022PLRXBuy Now
Pliant Therapeutics
$12.08173.18% → $33Initiates → BuyGet Alert
12/14/2022TVTXBuy Now
Travere Therapeutics
$9.92121.77% → $22Initiates → HoldGet Alert
09/16/2022VTYXBuy Now
Ventyx Biosciences
$2.581950.29%$45 → $53MaintainsBuyGet Alert
09/07/2022VTYXBuy Now
Ventyx Biosciences
$2.581640.81% → $45Initiates → BuyGet Alert
09/07/2022DICEBuy Now
DICE Therapeutics
→ $37Initiates → BuyGet Alert
09/07/2022MORFBuy Now
Morphic Holding
$56.47-22.08% → $44Initiates → BuyGet Alert
06/28/2022ARGXBuy Now
argenx
$468.96-1.91% → $460Reinstates → BuyGet Alert
06/28/2022KDNYBuy Now
Chinook Therapeutics
→ $30Initiates → BuyGet Alert